These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 14704599)

  • 1. Ciprofloxacin- and hypocalcemia-induced torsade de pointes triggered by hemodialysis.
    Daya SK; Gowda RM; Khan IA
    Am J Ther; 2004; 11(1):77-9. PubMed ID: 14704599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ciprofloxacin-induced torsade de pointes.
    Flanagan MC; Mitchell ES; Haigney MC
    Int J Cardiol; 2006 Nov; 113(2):239-41. PubMed ID: 16386810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ciprofloxacin-induced torsade de pointes.
    Ibrahim M; Omar B
    Am J Emerg Med; 2012 Jan; 30(1):252.e5-9. PubMed ID: 21075583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Torsades de pointes and long QT syndromes.
    Janeira LF
    Am Fam Physician; 1995 Oct; 52(5):1447-53. PubMed ID: 7572567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Torsade de pointes in initiating hemodialysis: a case report.
    Yang JA; Choi HS; Bae EH; Ma SK; Kim SW; Kim CS
    Ann Palliat Med; 2020 May; 9(3):1264-1268. PubMed ID: 32389016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time- and rate-dependent alterations of the QT interval precede the onset of torsade de pointes in patients with acquired QT prolongation.
    Gilmour RF; Riccio ML; Locati EH; Maison-Blanche P; Coumel P; Schwartz PJ
    J Am Coll Cardiol; 1997 Jul; 30(1):209-17. PubMed ID: 9207644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ciprofloxacin-induced torsades de pointes in a methadone-dependent patient.
    Nair MK; Patel K; Starer PJ
    Addiction; 2008 Dec; 103(12):2062-4. PubMed ID: 19469750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pause-dependent torsade de pointes following acute myocardial infarction: a variant of the acquired long QT syndrome.
    Halkin A; Roth A; Lurie I; Fish R; Belhassen B; Viskin S
    J Am Coll Cardiol; 2001 Oct; 38(4):1168-74. PubMed ID: 11583899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of prolonged QT interval and torsades de pointes due to ciprofloxacin.
    Salinas Arce J; Romero R; Solorzano P
    Rev Esp Cardiol; 2010 Jan; 63(1):111-2. PubMed ID: 20089234
    [No Abstract]   [Full Text] [Related]  

  • 10. QT interval prolongation, torsade de pointes and renal disease.
    Patanè S; Marte F; Di Bella G; Currò A; Coglitore S
    Int J Cardiol; 2008 Nov; 130(2):e71-3. PubMed ID: 18255176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. QT Interval prolongation and torsades de pointes due to a coadministration of ciprofloxacin and azimilide in a patient with implantable cardioverter-defibrillator.
    Kaźmierczak J; Peregud-Pogorzelska M; Rzeuski R
    Pacing Clin Electrophysiol; 2007 Aug; 30(8):1043-6. PubMed ID: 17669094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ciprofloxacin induced acquired long QT syndrome in a patient under class III antiarrhythmic therapy.
    Keivanidou A; Arnaoutoglou C; Krommydas A; Papanikolaou G; Tsiptses K; Chrisopoulos C; Kirpizidis C
    Cardiol J; 2009; 16(2):172-4. PubMed ID: 19387967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perioperative torsade de pointes ventricular tachycardia induced by hypocalcemia and hypokalemia.
    Soroker D; Ezri T; Szmuk P; Merlis P; Epstein M; Caspi A
    Anesth Analg; 1995 Mar; 80(3):630-3. PubMed ID: 7864442
    [No Abstract]   [Full Text] [Related]  

  • 14. Moxifloxacin-induced QT prolongation and torsades: an uncommon effect of a common drug.
    Badshah A; Janjua M; Younas F; Halabi AR; Cotant JF
    Am J Med Sci; 2009 Aug; 338(2):164-6. PubMed ID: 19680025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug therapy for torsade de pointes.
    Banai S; Tzivoni D
    J Cardiovasc Electrophysiol; 1993 Apr; 4(2):206-10. PubMed ID: 8269292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Torsade de pointes associated with moxifloxacin: a rare but potentially fatal adverse event.
    Altin T; Ozcan O; Turhan S; Ongun Ozdemir A; Akyurek O; Karaoguz R; Guldal M
    Can J Cardiol; 2007 Sep; 23(11):907-8. PubMed ID: 17876386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precordial QT interval dispersion as a marker of torsade de pointes. Disparate effects of class Ia antiarrhythmic drugs and amiodarone.
    Hii JT; Wyse DG; Gillis AM; Duff HJ; Solylo MA; Mitchell LB
    Circulation; 1992 Nov; 86(5):1376-82. PubMed ID: 1423949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquired prolongation of QT interval as a risk factor for torsade de pointes ventricular tachycardia: a narrative review for the anesthesiologist and intensivist.
    Uvelin A; Pejaković J; Mijatović V
    J Anesth; 2017 Jun; 31(3):413-423. PubMed ID: 28229241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Torsade de pointes: the clinical considerations.
    Gowda RM; Khan IA; Wilbur SL; Vasavada BC; Sacchi TJ
    Int J Cardiol; 2004 Jul; 96(1):1-6. PubMed ID: 15203254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ciprofloxacin-induced acquired long QT syndrome.
    Prabhakar M; Krahn AD
    Heart Rhythm; 2004 Nov; 1(5):624-6. PubMed ID: 15851230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.